Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

HUMALOG LISPRO for Type 1 diabetes mellitus: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 76 adverse event reports in the FDA FAERS database where HUMALOG LISPRO was used for Type 1 diabetes mellitus.

Most Reported Side Effects for HUMALOG LISPRO

Side Effect Reports % Deaths Hosp.
Blood glucose increased 172 39.5% 3 96
Blood glucose decreased 46 10.6% 0 22
Diabetic ketoacidosis 46 10.6% 0 38
Drug ineffective 29 6.7% 0 17
Malaise 28 6.4% 1 10
Hypoglycaemia 25 5.8% 0 16
Fall 23 5.3% 1 16
Blindness 19 4.4% 1 5
Incorrect dose administered 19 4.4% 1 12
Drug dose omission 18 4.1% 0 9
Hypoglycaemic unconsciousness 18 4.1% 1 10
Visual acuity reduced 16 3.7% 0 6
Underdose 15 3.5% 0 8
Cataract 14 3.2% 0 6
Cerebrovascular accident 14 3.2% 1 9

Other Indications for HUMALOG LISPRO

Product used for unknown indication (137) Type 2 diabetes mellitus (116) Diabetes mellitus (96)

Other Drugs Used for Type 1 diabetes mellitus

INSULIN LISPRO (9,401) INSULIN GLARGINE (6,569) INSULIN ASPART (3,913) INSULIN HUMAN (2,150) INSULIN DEGLUDEC (1,459) INSULIN DETEMIR (794) INSULIN GLULISINE (569) DEVICE (495) CANAGLIFLOZIN (422) EMPAGLIFLOZIN (383)

Related Pages

HUMALOG LISPRO Full Profile All Type 1 diabetes mellitus Drugs HUMALOG LISPRO Demographics HUMALOG LISPRO Timeline